Editor’s Note
**Editor’s Note:** Galderma’s Alastin expands into the Japan-Pacific region, launching in Taiwan with plans for Japan, Singapore, and South Korea by year-end, targeting the growing post-procedure skincare market.
Global dermatology leader Galderma has announced that its premium regenerative skincare brand Alastin is officially entering the Japan-Pacific (JPAC) region. The brand recently launched in Taiwan and plans to roll out in Japan, Singapore, and South Korea by the end of this year, targeting the rapidly growing post-procedure skincare market.
Galderma noted that this expansion follows Alastin’s previous launches in China and Australia, underscoring the brand’s commitment to the JPAC region. The area is characterized by advanced skincare awareness and rapid growth in minimally invasive injectable aesthetics, with consumers increasingly seeking integrated skincare solutions that enhance skin barrier function, support post-procedure recovery, and maintain long-term skin quality.
The Alastin product line focuses on amplifying the skin’s natural regenerative capacity and can be used alongside energy-based devices (such as lasers, radiofrequency, and ultrasound) and injectable treatments to shorten recovery time and enhance visible results. Some products feature the patented TriHex Technology®, which uses a peptide complex to clear aged and damaged collagen and elastin while promoting the production of healthy collagen.
